Extrahepatic targets and cellular reactivity of drug metabolites
- PMID:25174932
- DOI: 10.2174/0929867321666140826113716
Extrahepatic targets and cellular reactivity of drug metabolites
Abstract
Biotransformation is one of the key elements of chemically induced toxicity. Although organisms have an intrinsic tendency to diminish the harm posed by chemical exposure with or without structural modification and excretion of the agents (detoxification), this is not always the case; toxification may also occur. The liver has evolved to be the center of biotransformation from the anatomical, physiological and biochemical points of view; it is located alongside the stomach and intestine, it receives more than 25% of the cardiac output and it contains, in general, the richest quantity but also variety of drug metabolizing enzymes. That is why many orally taken drug-induced toxic effects are seen in the liver. Nevertheless, non-hepatic tissues in the organism are also subjected to toxic insult. Although several instances have suggested transport of liver-bioactivated reactive metabolites to the target tissue is responsible, such as monocrotaline-associated lung toxicity, tetraethyl lead- and n-hexane-associated nervous system toxicity and 2-methoxyethanol-associated testis toxicity, etc. [1], the vast majority of data show local bioactivation in the target tissue is responsible for the extrahepatic toxic outcome. The impact of extrahepatic bioactivation and toxicity of drugs can also be seen in cases of drug attrition due to unacceptable toxicity; adverse cardiovascular effects were the foremost reason for drug withdrawals between 1993 and 2006 [2]. On the other hand, the parent drug and/or its stable metabolite( s) may also cause adverse effects such as inhibition of transporters, occlusion of bile secretion (cholestasis) and accumulation in organelles such as mitochondria, causing steatosis in liver and possibly in other organs. However, this review attempts to summarize only extrahepatic bioactivation of drugs/chemicals and their effects at the cellular and tissue level. Specifically, it focuses on the two most perfused organs, lung and heart tissue, as well as thyroid, blood, brain, and skin. Clozapine, a still-in-use drug with severe off-target toxicities (agranulocytosis and cardiovascular toxicity), is investigated in depth and various drugs are reviewed with a special emphasize on the other mentioned organs.
Similar articles
- Effects of inducers and inhibitors on drug-metabolizing enzymes and on drug toxicity in extrahepatic tissues.Boyd MR.Boyd MR.Ciba Found Symp. 1980;76:43-66. doi: 10.1002/9780470720592.ch4.Ciba Found Symp. 1980.PMID:6780280
- Drug bioactivation, covalent binding to target proteins and toxicity relevance.Zhou S, Chan E, Duan W, Huang M, Chen YZ.Zhou S, et al.Drug Metab Rev. 2005;37(1):41-213. doi: 10.1081/dmr-200028812.Drug Metab Rev. 2005.PMID:15747500Review.
- Conventional and novel approaches in generating and characterization of reactive intermediates from drugs/drug candidates.Orhan H, Vermeulen NP.Orhan H, et al.Curr Drug Metab. 2011 May;12(4):383-94. doi: 10.2174/138920011795202974.Curr Drug Metab. 2011.PMID:21395525Review.
- Are chemically reactive metabolites responsible for adverse reactions to drugs?Williams DP, Kitteringham NR, Naisbitt DJ, Pirmohamed M, Smith DA, Park BK.Williams DP, et al.Curr Drug Metab. 2002 Aug;3(4):351-66. doi: 10.2174/1389200023337423.Curr Drug Metab. 2002.PMID:12093355Review.
- Metabolic activation as a basis for organ-selective toxicity.Boyd MR, Grygiel JJ, Minchin RF.Boyd MR, et al.Clin Exp Pharmacol Physiol. 1983 Jan-Feb;10(1):87-99. doi: 10.1111/j.1440-1681.1983.tb00175.x.Clin Exp Pharmacol Physiol. 1983.PMID:6340874Review.
Cited by
- Antipsychotics cardiotoxicity: What's known and what's next.Li XQ, Tang XR, Li LL.Li XQ, et al.World J Psychiatry. 2021 Oct 19;11(10):736-753. doi: 10.5498/wjp.v11.i10.736. eCollection 2021 Oct 19.World J Psychiatry. 2021.PMID:34733639Free PMC article.Review.
- Metabolic and cardiovascular benefits and risks of 4-hydroxy guanabenz hydrochloride: α2-adrenoceptor and trace amine-associated receptor 1 ligand.Kotańska M, Marcinkowska M, Kuder KJ, Walczak M, Bednarski M, Siwek A, Kołaczkowski M.Kotańska M, et al.Pharmacol Rep. 2023 Oct;75(5):1211-1229. doi: 10.1007/s43440-023-00518-9. Epub 2023 Aug 25.Pharmacol Rep. 2023.PMID:37624466Free PMC article.
- Deep Learning to Predict the Formation of Quinone Species in Drug Metabolism.Hughes TB, Swamidass SJ.Hughes TB, et al.Chem Res Toxicol. 2017 Feb 20;30(2):642-656. doi: 10.1021/acs.chemrestox.6b00385. Epub 2017 Feb 2.Chem Res Toxicol. 2017.PMID:28099803Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical